뉴스벤징가
Novo Nordisk Loses Court Bid Against Eli Lilly’s Weight-Loss Drug Ads — Judge Says Sales Impact Was Negligible (UPDATED)
· 발표
기사 요약
Novo Nordisk fails to block Eli Lilly’s weight-loss drug ads as a judge finds little evidence of market impact or lasting harm.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…